What were the results of the primary objective (postoperative recovery quality measured by the QoR‑15 questionnaire on postoperative day 1 and day 2) in the second study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Primary Outcome Results from the Second Study

The second study 1 found that PROMs-guided postoperative care resulted in a mean difference of 5.5 points (95% credibility interval: 2.3 to 9.2) higher QoR-15 score at postoperative day 35 compared to standard care, though this fell short of the minimal clinically important difference of 6.0 points.

Detailed Primary Outcome Analysis

The primary endpoint in this 2026 randomized controlled trial was the change in QoR-15 scores between the preoperative period and postoperative day 35 1. The study specifically measured:

  • Absolute difference: 5.5 points improvement in the experimental (PROMs-guided) group
  • Statistical certainty: Probability that this difference is greater than zero was >99.9%
  • Clinical significance: Only 39.4% probability that the difference exceeded the MCID threshold of 6 points

Key Interpretation

While the intervention showed a statistically significant benefit with near-certainty (Pr(diff > 0) > 0.999), the clinical relevance was limited as the improvement did not reliably exceed the 6-point MCID for the QoR-15 scale 1. This represents a statistically positive but clinically marginal improvement in postoperative recovery quality.

The study used Bayesian analytical methods and assessed QoR-15 at multiple timepoints (POD 1,3,14, and 28) before the primary endpoint measurement at POD 35 1.

Important Context

The study did demonstrate a clinically meaningful secondary benefit: a 97.4% probability of reduced persistent opioid consumption in the PROMs-guided group (12.3%) compared to standard care (21.2%) 1, which may represent the more clinically relevant outcome from this intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.